Severe Adverse Event Webinar
SAE Webinar Background:
Adverse events (AEs) particularly severe adverse events (SAEs) during and following mass drug administration have a serious effect not only on the people who are affected directly, but also on the viability of the MOH’s national NTD control program.
Partners ensure that the NTDP /MOH program has access to resources for prevention, management and reporting on SAEs. It is also important to stress the importance of notification and reporting to partners including the World Health Organization, global drug donation programs and Pharma, and other partners such as NGOs.
Note: Times on the agenda are UTC times. The webinar will begin at 12:00 pm ET/16:00 UTC.
Goal:
The purpose of this webinar is to share current resources, tools, and brochures including updates available for the management of SAE and to stress the need to notify and report to the partners.
Type
Tool, Training Materials
Year of publication
Disease
All Preventive Chemotherapy NTDs
Country
All Countries, Benin, Burkina Faso, Cameroon, Cote d’Ivoire, Ghana, Guinea, Mali, Niger, Senegal, Sierra Leone, Togo
Focus Areas
Mass Drug Administration (MDA), MDA implementation, Community outreach, Drug procurement & supply chain support, Cross-border initiatives, Annual training for MDA, Monitoring, Evaluation, Research, Learning and Adapting (MERLA), Disease-specific assessments, post-treatment surveillance, and related training, Disease & morbidity mapping & assessment, Learning & quality improvement, Data for decision-making, Operational research, Dossier development
Media Type
Event or Webinar Handout
Partners
FHI360